Hudson Value Partners »

Regeneron Pharmaceuticals shares owned by Hudson Value Partners

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Hudson Value Partners from 13F filings

Historical chart of Hudson Value Partners investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Hudson Value Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Hudson Value Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $427k 759 562.27
2025-06-30 $399k 759 525.00

More positions owned by Hudson Value Partners

Berkshire Hathaway Inc Del Cl B Stock (BRK.B)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Apple Stock (AAPL)
Microsoft Corp Stock (MSFT)
Nvidia Corporation Stock (NVDA)
Visa Inc Com Cl A Stock (V)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Costco Whsl Corp Stock (COST)
Asml Holding N V N Y Registry Adr (ASML)
Corning Stock (GLW)
Vanguard Total Stock Market Etf Call Call Option
Builders Firstsource Stock (BLDR)
Franco Nev Corp Stock (FNV)
Everus Constr Group Stock (ECG)
Vanguard Total Stock Market Etf Etf (VTI)

View all positions for Hudson Value Partners

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
State Street Corporation
Dodge & Cox
Jpmorgan Chase & Co
Geode Capital Management
Franklin Resources
Capital World Investors
Loomis, Sayles and
FMR
Invesco
Susquehanna International
Morgan Stanley
Goldman Sachs Group
Nuveen

View all funds holding Regeneron Pharmaceuticals